Identification of specific tumor necrosis factor-α-susceptible and -protective haplotypes associated with the risk of type 1 diabetes

European Cytokine Network

Volumn 21, Issue 4, 2010, Pages 285-291

  Stayoussef, Mouna ^a   Benmansour, Jihen ^a   Al Jenaidi, Fayza A ^b,c   Rajab, Mansoor H ^b   Said, Hichem B ^d   Ourtani, Mohamed ^e   Rayana, Chiheb B ^a   Mahjoub, Touhami ^a   Almawi, Wassim Y ^c  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b Salmaniya Medical Complex ^*  (Bahrain)

^c ARABIAN GULF UNIVERSITY   (Bahrain)

^d FARHAT HACHED HOSPITAL   (Tunisia)

^e Hospital of Kairouan   (Tunisia)

Author keywords

Polymorphisms; Tumor necrosis factor; Type 1 diabetes

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; GLYCEMIC CONTROL; HAPLOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; ALLELES; CASE-CONTROL STUDIES; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MATCHED-PAIR ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 78650445020     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: 10.1684/ecn.2010.0215     Document Type: Article

References (38)

1. Atkinson MA, Eisenbarth GS. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 2001; 358: 221.
2. Donaghue KC, Chiarelli F, Trotta D, Allgrove J, Dahl-Jorgensen K. Microvascular and macrovascular complications associated with diabetes in children and adolescents. Pediatr Diabetes 2009; 10 (Suppl. 12): 195.
3. Dotta F, Fondelli C, Di Mario U. Type 1 diabetes mellitus as a polygenic multifactorial disease: immunopathogenic mechanisms of beta-cell destruction. Acta Biomed 2005; 76 (Suppl. 3): 14.
4. Al-Jenaidi FA, Wakim-Ghorayeb SF, Al-Abbasi A, et al. Contribution of selective HLA-DRB1/DQB1 alleles and haplotypes to the genetic susceptibility of type 1 diabetes among Lebanese and Bahraini Arabs. J Clin Endocrinol Metab 2005; 90: 5104.
5. Kockum I, Sanjeevi CB, Eastman S, Landin-Olsson M, Dahlquist G, Lernmark A. Complex interaction between HLA DR and DQ in conferring risk for childhood type 1 diabetes. Eur J Immunogenet 1999; 26: 361.
6. Valdes AM, Erlich HA, Noble JA. Human leukocyte antigen class I B and C loci contribute to Type 1 Diabetes (T1D) susceptibility and age at T1D onset. Hum Immunol 2005; 66: 301.
7. Jiménez-Morales S, Velázquez-Cruz R, Ramírez-Bello J, et al. Tumor necrosis factor-alpha is a common genetic risk factor for asthma, juvenile rheumatoid arthritis, and systemic lupus erythematosus in a Mexican pediatric population. Hum Immunol 2009; 70: 251.
8. Puthothu B, Bierbaum S, Kopp MV, et al. Association of TNFalpha with severe respiratory syncytial virus infection and bronchial asthma. Pediatr Allergy Immunol 2009; 20: 157.
9. de Paz B, Alperi-López M, Ballina-García FJ, et al. Interleukin 10 and tumor necrosis factor-alpha genotypes in rheumatoid arthritis-association with clinical response to glucocorticoids. J Rheumatol 2010; 37: 503.
10. Ferguson LR, Huebner C, Petermann I, et al. Single nucleotide polymorphism in the tumor necrosis factor-alpha gene affects inflammatory bowel diseases risk. World J Gastroenterol 2008; 14: 4652.
11. Lu Z, Chen L, Li H, Zhao Y, Lin L. Effect of the polymorphism of tumor necrosis factor-alpha-308 G/A gene promoter on the susceptibility to ulcerative colitis: a meta-analysis. Digestion 2008; 78: 44.
12. Feng RN, Li Y, Sun C.H. TNF 308 G/A polymorphism and type 1 diabetes: a meta-analysis. Diabetes Res Clin Pract 2009; 85: e4.
13. Kumar R, Goswami R, Agarwal S, Israni N, Singh SK, Rani R. Association and interaction of the TNF-alpha gene with other proand anti-inflammatory cytokine genes and HLA genes in patients with type 1 diabetes from North India. Tissue Antigens 2007; 69: 557.
14. Settin A, Ismail A, El-Magd MA, El-Baz R, Kazamel A. Gene polymorphisms of TNF-alpha-308 (G/A), IL-10(-1082) (G/A), IL-6(-174) (G/C) and IL-1Ra (VNTR) in Egyptian cases with type 1 diabetes mellitus. Autoimmunity 2009; 42: 50.
15. Shin HD, Yang SW, Kim DH, Park Y. Independent association of tumor necrosis factor polymorphism with type 1 diabetes susceptibility. Ann N Y Acad Sci 2008; 1150: 76.
16. Hehlgans T, Pfeffer K. The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games. Immunology 2005; 115: 1-20.
17. Bilgic S, Aktas E, Salman F, et al. Intracytoplasmic cytokine levels and neutrophil functions in early clinical stage of type 1 diabetes. Diabetes Res Clin Pract 2008; 79: 31.
18. Sarkar SA, Kutlu B, Velmurugan K, et al. Cytokine-mediated induction of anti-apoptotic genes that are linked to nuclear factor kappa-B (NF-kappaB) signalling in human islets and in a mouse beta cell line. Diabetologia 2009; 52: 1092.
19. Kharroubi I, Ladrière L, Cardozo AK, Dogusan Z, Cnop M, Eizirik DL. Free fatty acids and cytokines induce pancreatic beta-cell apoptosis by different mechanisms: role of nuclear factor-kappaB and endoplasmic reticulum stress. Endocrinology 2004; 145: 5087.
20. Sharma S, Sharma A, Kumar S, Sharma SK, Ghosh B. Association of TNF haplotypes with asthma, serum IgE levels, and correlation with serum TNF-alpha levels. Am J Respir Cell Mol Biol 2006; 35: 488.
21. Skoog T, Eriksson P, Hoffstedt J, Ryden M, Hamsten A, Arner P. Tumour necrosis factor-a (TNF-a) polymorphisms -857C/A and - 863C/A are associated with TNF-a secretion from human adipose tissue. Diabetologia 2001; 44: 654.
22. Hernandez-Guerrero C, Monzon-Bordonaba F, Jimenez-Zamudio L, et al. In vitro secretion of proinflammatory cytokines by human amniochorion carrying hyper-responsive gene polymorphisms of tumour necrosis factor-a and interleukin-1ß. Mol Hum Reprod 2003; 9: 625.
23. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor a promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94: 3195.
24. Noble JA, Valdes AM, Lane JA, Green AE, Erlich HA. Linkage disequilibrium with predisposing DR3 haplotypes accounts for apparent effects of tumor necrosis factor and lymphotoxin-alpha polymorphisms on type 1 diabetes susceptibility. Hum Immunol 2006; 67: 999.
25. Nishimura M, Obayashi H, Mizuta I, et al. TNF, TNF receptor type 1, and allograft inflammatory factor-1 gene polymorphisms in Japanese patients with type 1 diabetes. Hum Immunol 2003; 64: 302.
26. Stayoussef M, Al-Jenaidi FA, Al-Abbasi A, et al. Modulation of type 1 diabetes susceptibility by tumor necrosis factor alpha -308 G/A and lymphotoxin alpha +249 A/G haplotypes and lack of linkage disequilibrium with predisposing DQB1-DRB1 haplotypes in Bahraini patients. Clin Vaccine Immunol 2008; 15: 379.
27. Siekiera U, Jarosz-Chobot P, Janusz J, Koehler B. Polymorphism of TNF-alpha (308 A/G), IL-10 (1082 A/G, 819 C/T 592 A/C), IL-6 (174 G/C), and IFN-gamma (874 A/T); genetically conditioned cytokine synthesis level in children with diabetes type 1. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw 2002; 8: 29.
28. Aminkeng F, Van Autreve JE, Koeleman BP, et al. Belgian Diabetes Registry. TNFa microsatellite polymorphism modulates the risk of type 1 diabetes in the Belgian population, independent of HLA-DQ. Hum Immunol 2007; 68: 690.
29. Wirz SA, Morale MC, Marchetti B, et al. High frequency of TNF alleles -238A and -376A in individuals from northern Sardinia. Cytokine 2004; 26: 149.
30. Suk K, Kim S, Kim YH, et al. IFN-gamma/TNF-alpha synergism as the final effector in autoimmune diabetes: a key role for STAT1/IFN regulatory factor-1 pathway in pancreatic beta cell death. J Immunol 2001; 166: 4481.
31. Yoon JW, Jun HS, Santamaria P. Cellular and molecular mechanisms for the initiation and progression of beta cell destruction resulting from the collaboration between macrophages and T cells. Autoimmunity 1998; 27: 109.
32. Knight JC, Udalova I, Hill AV, et al. A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet 1999; 22: 145.
33. Mullighan CG, Fanning GC, Chapel HM, Welsh KI. TNF and lymphotoxin-alpha polymorphisms associated with common variable immunodeficiency: role in the pathogenesis of granulomatous disease. J Immunol 1997; 159: 6236.
34. Boraska V, Skrabic V, Culic VC, Becic K, Kapitanovic S, Zemunik T. Association of TNF promoter polymorphisms with type 1 diabetes in the South Croatian population. Biol Res 2008; 41: 157.
35. Shbaklo H, Azar ST, Terwedow H, Halaby G, Naja RP, Zalloua PA. No association between the -1031 polymorphism in the TNFalpha promoter region and type 1 diabetes. Hum Immunol 2003; 64: 633.
36. Garcia-Merino A, Alper CA, Usuku K, et al. Tumor necrosis factor (TNF) microsatellite haplotypes in relation to extended haplotypes, susceptibility to diseases associated with the major histocompatibility complex and TNF secretion. Hum Immunol 1996; 50: 11.
37. Poirot L, Benoist C, Mathis D. Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity. Proc Natl Acad Sci USA 2004; 101: 8102.
38. Rodacki M, Svoren B, Butty V, et al. Altered natural killer cells in type 1 diabetic patients. Diabetes 2007; 56: 177.